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A single-centre investigator-blinded randomised parallel-group
study protocol to investigate the influence of an acclimatisation
appointment on children’s behaviour during N2O/O2 sedation
as measured by psychological, behavioural and real-time
physiological parameters
Mawlood Kowash 1, Manal Al-Halabi1, Iyad Hussein 1, Mohammad M. Abdo1, Anas Salami1, Amar Hassan1, Yrsa Sverrisdottir2 and
Jinous F. Tahmassebi3
AIMS AND OBJECTIVES: To describe a study protocol of a randomised control trial (RCT) assessing the effectiveness, in reducing
dental anxiety, of an acclimatising nitrous oxide sedation (N2O) session prior to actual dental treatment with N2O.
MATERIALS AND METHODS: A single-centre investigator-blinded parallel-group RCT conducted in a postgraduate dental hospital in
Dubai, United Arab Emirates (UAE). Anxious children requiring N2O (aged 5–15 years) will be randomly assigned to; a study group: children
who will have a preparatory N2O trial experience or; a control group: children who will only have N2O explained to them. Treatment
with N2O for both groups will start at the second visit. The following outcomes will be recorded: completion of dental treatment, anxiety
scores at baseline and after treatment (using the Modified Child Dental Anxiety Scale faces), behaviour of the child (using Frankl
Rating Behaviour Scale) and the acquisition of real-time physiological anxiety-related parameters (using E4® electronic wrist devices).
RESULTS: The data will be analysed statistically.
DISCUSSION: There is a paucity of research regarding dental N2O acclimatising appointments. This RCT will supplement existing literature.
CONCLUSIONS: This RCT will report whether prior acclimatising of a child to N2O sedation is effective, or not, in improving dental
treatment behaviour.
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STRENGTHS AND LIMITATIONS
● No previous study has investigated the effect of an N2O/O2
sedation acclimatisation visit on children’s anxiety and stress
levels as measured by psychological, behavioural and real-
time physiological parameters.
● This study will provide evidence to support the experts’ opinion
regarding the implementation of an acclimatisation visit.
● The study will establish an effective method in the child’s
pharmacological behaviour management.
● However, it may expose the child to an additional N2O
intervention and increase patient contact time which may affect
patient compliance.
INTRODUCTION
Nitrous oxide inhalation sedation (nitrous oxide/oxygen—N2O/O2
or N2O for short) is a mild method of anxiolytic sedation. It is a
combination of nitrous oxide and oxygen breathed through a
snugly fitting nosepiece, using a special delivery device with
robust safety features. This aids the anxious child to feel at ease
and allow for dental treatment.1,2 It is a known fact that fear and
anxiety from dentistry are the most commonly known barriers to
receiving actual dental treatment,3 with millions of patients
reporting that they, if offered some type of anxiolysis/sedation,
would be more amenable to accepting dental procedures.4
The utilisation of N2O or general anaesthesia (GA) is advised
by contemporary guidelines to enable the performance of
dental treatment in children. This is the case when non-
pharmacological behaviour shaping methods fail to lessen
children’s anxiety and fear,2 and where invasive dental treatment
(such as extractions and restorations) are needed particularly in
countries that have a very high rate of dental decay such as the
United Arab Emirates.5,6
The application of N2O for dental procedures is essentially
reliant on the child’s cooperation, allowance of and maintenance
of the N2O nasal piece to remain securely in position. If N2O is
gradually titrated to the appropriate levels for the said child, it
provides a mild plane of sedation and anxiolysis to allow for
dental treatment.1,2
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It is suggested that the use of an acclimatisation (familiarisation)
visit, defined to be a session in which N2O sedation is solely
provided, with no or minimal dental intervention, would enhance
the acceptability and the efficacy of N2O success.
2 This principle
may be contentious. It may increase treatment success and
compliance, based on the concepts of graded exposure and
cognitive behaviour therapy,7 which are behind many well-utilised
behaviour shaping modalities. However, it may expose the child
patient to further pharmacological intercession and increase
patient–dentist contact time, subsequently impacting adversely
on patient compliance.
The use of an acclimatising N2O session had historically been
suggested.8 While the sedation guidelines of the Royal Colleges of
Surgeons and the Royal College of Anaesthetists in the United
Kingdom in 2015 proposed two visits for N2O—an assessment
session without the use of N2O—and a treatment session, they
recommended N2O to be administered at the first visit in cases of
dental emergencies only.9 Nevertheless, and most recently, other
authorities reverted back to the classical viewpoint. For example,
the Scottish Dental Clinical Effectiveness Programme (SDCEP) as
recent as 2017 recommended the use of an introductory visit
stating “a brief trial of nitrous oxide/oxygen at the assessment
appointment may be helpful for the psychological preparation of
some children”.2 Therefore, the aforementioned guidelines have
advocated the use of an N2O accustoming appointment. Never-
theless, and to our awareness, there are no clinical studies that
have investigated the effectiveness of such an acclimatisation visit
of N2O sedation on the acceptance of the child patients of dental
procedures. In addition, no robust, methodically designed and
objective randomised control trials exist, to our knowledge, to
assess if this preparatory appointment would lead to an
enhancement in the patients’ performance and behaviour during
the dental procedure.
THE AIMS OF THE STUDY
This study is a randomised controlled two-arm trial with a single-
centre, single-blinded, parallel-group design. The aims of this
clinical research project are to assess the outcome and effect of
conducting a short acclimatising preparatory appointment, of 15-
min duration using N2O sedation, on the objectively assessed
behaviour of child dental patients and their perceived and
measured levels of anxiety during dental treatment. In addition,
this study aims to relate and compare this effect in the study
group, with that of a group of children who undergo standard
dental treatment without the preparatory accustoming appoint-
ment of N2O sedation.
The null hypothesis
The employment of an acclimatising appointment of N2O
sedation, preceding the instigation of dental treatment will not
bring about an enhancement in the child’s behaviour and will not
lead to a decrease in anxiety levels throughout dental treatment.
MATERIALS AND METHODS
The outline of the suggested study is that of a single-centre,
single-blinded (to dental surgeon and physiologist investigators),
parallel-group randomised controlled two-arm clinical trial,
adhering to the guidelines of the CONSORT Group (Schulz et al.,
2010)10 and to reporting checklist for protocol of a clinical trial
based on the SPIRIT guidelines. The overall trial start date (from
idea conception) is 01/02/2018, and the proposed end date will be
15/10/2020.
Primary outcome
The changes in the child’s behaviour and anxiety levels. The
primary outcome measures will be assessed by
(a) Physiologically measurable parameters by using a medical
grade wearable device (E4® wrist bands—Empatica Inc., 1
Broadway, Cambridge, MA 02142, United States—ISO 13485
Cert. No. 9124.EPTC). These parameters are
● Electrodermal activity (EDA) also known as Galvanic skin
response (GSR),
● Blood volume pulse (BVP),
● Heart rate (HR),
● Surface skin temperature.
(b) Dental anxiety scores at baseline before the (acclimatisation
session) and after treatment (second session) using the
Modified Child Dental Anxiety Scale-face version (MCDASf).11
(c) Children’s behaviour score will be recorded using the Frankl
Behaviour Rating Scale (FBRS).12
Secondary outcomes
The following clinical outcomes will be obtained and considered as
indications of a beneficial effect of the acclimatisation N2O session:
(a) The successful completion of the required dental procedure
as measured by reviewing the clinical notes documents
obtained from the electronic dental records system.
(b) The children’s and parents’ acceptance of the treatment
with or without acclimatisation session as measured by
guardian/child quantitative questionnaire (see below
Table 1a, b).
Inclusion and exclusion criteria
● Inclusion criteria
- Children (aged 5–15 years old) presenting with their parents,
who are referred to the paediatric dentistry department in Dubai
Dental Hospital (DDH) [the only secondary specialist dental
hospital in Dubai, United Arab Emirates (UAE)], for dental
treatment under N2O within a 6 months’ period will be invited
to participate in the study.
- Healthy children indicated for dental treatment under N2O with
American Society of Anesthesiologists (ASA) classification of I or II.13
- No learning disabilities impeding N2O sedation acceptance.
UAE and non-UAE nationals’ parents and children will be eligible to
participate in the study.
- The children should have no previous experience of N2O inhalation
sedation.
● Exclusion criteria
- Medically compromised children and/or individuals with special
healthcare needs.
- Patients diagnosed with a psychiatric disorder.
- Children who lack communication due to languages barriers.
- Children whose parents refuse to participate in the study.
- Patients with contraindications for the use of N2O, such as
patients who have upper respiratory tract infections (common
cold), mouth breathers due to nasal adenoids.
- Patients with obvious skin conditions such as eczema or psoriasis
that may impede the use of the E4® wrist bands and impair their
conductivity.
Study flow and layout
A layout of the clinical study is presented in the flowchart seen in
Fig. 1. After the initial examination by the clinical investigator,
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eligibility verification, participant’s assent and parents’/guardian’s
signing the informed consent, the study participants will be
randomly assigned to either the control or study group (33
patients per group). The study group will include families (children
and parents) who are in need of N2O sedation at DDH (Dubai,
UAE), who would attend a visit for prevention where N2O sedation
will be introduced and experienced while the control group will
be the families who would attend for a prevention visit and
discussion of the sedation procedure only without any actual
introduction to N2O.
A 1:1 allocation-based block randomisation method will be
employed. The method of allocation concealment will be attained
by using matching, sealed, serially numbered, non-transparent
envelopes that will contain group allocation. The envelopes
will be opened in sequence by a non-investigator (dental
assistant), only after the envelope has been conclusively
dispensed to each partaker and will continue to be anonymous
to the clinical team.
At the initial screening visit, the anxiety level will be recorded
using MCDASf (Fig. 2) to determine the need for N2O sedation and
subsequently invite the child and parents to participate in the
study. Once enroled, an acclimatising visit will be carried out by a
single paediatric dentist who will not be involved in the
subsequent treatment of the patients. To be constant, an
information script will be organised and rehearsed so that the
same preoperative instructions about N2O sedation will be
delivered to all the children and their parents. The patient’s
physiological signs will be recorded using the E4® wrist band
(Fig. 3). For the study group only, 15 min of N2O sedation will be
administered without any dental treatment procedures at the
acclimatisation visit.
Throughout the second visit, the dental treatment for both
study and control groups will include administering local
anaesthesia and restoration of carious teeth, pulp treatment if
needed and/or tooth/teeth extractions. The dental treatment will
be carried out by the same paediatric dentist. However, a second
paediatric dentist blinded to which group the child belongs to will
record the FBRS of children while receiving the treatment under
N2O sedation.
The MCDASf (see Fig. 2) using the SDCEP endorsed and
condensed version of the MCDASf questionnaire,11 not including
the last two questions on dental sedation and GA, will be used for
all anxious children. The MCDASf is a validated tool that had been
used to assess dental anxiety.14–16
The language of the MCDASf questionnaire will be English or
Arabic. The English version was translated into Arabic using the
forward and backward translation method. The translation was
checked by an independent bilingual expert who resolved
concerns and discrepancies. To make sure that the translation
was effective, a back-translation to the English language was done
by an independent translator who back-translated the question-
naire and discrepancies in the translation version were resolved.
The total score range of MCDASf is 6–30. Children with a score ≥19
will be considered to have severe dental anxiety (dental phobia),
while those with a score of <19 will be considered to have none to
moderate anxiety (Table 2).7 The treatment complexity rank score
(Table 3) records the medical status classification, based on the
patient’s (ASA) classification.13
In addition to the MCDASf, physiological anxiety-related
changes will be recorded using E4® wrist bands (see Fig. 3). The
wrist band will be placed 5min before the patient comes into the
surgery for treatment and will be taken off 5 min after the
completion of treatment. This will enable recording physiological
parameters continuously before, during and after the dental
treatment. E4® wrist bands will provide real-time parameters
(Fig. 4) such as EDA also known as GSR, BVP, acceleration, HR, and
temperature. E4® wrist bands are small, simulate wearing a
wristwatch, and we do not anticipate any increase in the children’s
anxiety as a result of wearing these wrist bands. The E4® wrist
band was validated17 and approved by the United States Food
and Drug Administration as a medical device. It is used in a wide
range of research settings with configurations for palmar skin
conductance measurement or using gelled electrodes secured
under the band. Additional evaluation of behaviour (Table 4) will
be documented using the numerical FBRS scores (FBRS: 1–4,
where 1 is very uncooperative).12 Parents and children will be
asked to fill in the survey questionnaire after completion of dental
treatment visit to assess their perception and approval (or lack of)
Table 1. Parent’s (a) and children’s (b) dental treatment acceptance questionnaire.
(a) Parent’s dental treatment acceptance questionnaire
Statements Response
Strongly agree Agree No opinion Disagree Disagree Strongly
The dentist explained very well why my child needed dental treatment.
I have no concerns about how the laughing gas sedation works.
I think the laughing gas sedation is doing a good job at helping my child
to cope with the treatment
My child coped well with having the laughing gas sedation.
The dental team were kind and helpful during my child’s treatment.
(b) Children’s dental treatment acceptance Questionnaire
Questions Response
Positive Neutral Negative
What do you think about your experience with laughing gas?
Are you glad to have your tooth fixed/extracted?
How did we look after you when you had your treatment?
How friendly were we when you came to see us?
How well did the dentist explain everything about treating your tooth?
Was it ok having your tooth fixed/extracted?
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of dental treatment with or without an accustoming session
(Table 1a, b).
Calculation of the study’s sample size
The study is sized to have an 80% power to detect a statistically
significant difference in children’s behaviour and anxiety level
between the two groups. As there are no previous similar studies,
the primary outcome measure is a change in anxiety (a reduction
mainly). To our knowledge, no studies had investigated the effect
of an acclimatising session of N2O on the child’s behaviour to base
our sample size calculation on. Our biostatistician used Houpt
et al. study in 1996 (effects of nitrous oxide on diazepam sedation
of young children) to predict the sample size.18 The predicted
sample size is 33 participants in each group and to compensate
for dropouts a total of 70 participants will be recruited for both
groups.
Role of the participants and the general public in the study
What was the research question, the outcome and outcome
measures of the study and how were they developed? A pilot
questionnaire to explore the usefulness of an N2O acclimatising
appointment prior to actual treatment, from the participants’
point of view was carried out in a group of 15 child participants
(range: 5–15 years). The outcome of this survey was indecisive
with 8 out of 15 children expressing a predilection for
commencing treatment without an acclimatising session to N2O.
This resulted in the formulation of the primary outcome measure
of our study on investigating the differences in the participants
reported dental anxiety scale in children belonging to the study
and control groups.
What were the preferences and experiences of the participants and
their influence in designing the study? We asked the aforemen-
tioned children regarding their feeling in carrying out the
completion of the MCDASf (anxiety survey). All the children in
this survey mentioned that completing MCDASf was acceptable to
them. In addition, we showed and placed the E4 watch on their
wrists and asked if they would be happy to wear the watch
throughout the treatment. Out of 15 children, 13 were happy with
wearing the E4 watch; 2 children found it uncomfortable.
Involvement of participants in the recruitment to and conduct of
the study. The potential participants will already be patients
indicated for N2O sedation and are on the DDH sedation list.
Ethical aspects and approval
This study will be conducted in full conformance with principles of
the “Declaration of Helsinki”, Good Clinical Practice, and within the
laws and regulations of the UAE/Dubai Healthcare City. Partici-
pants (legal guardians and children) who meet the aforemen-
tioned inclusion criteria will be enroled in this study. An informed
consent (verbal and written) will be provided to the parents/
Fig. 1 Flowchart of the study design.
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caregivers of the child before the N2O sedation and enrolment in
the study. Partakers and their parents/guardians will be appro-
priately informed about the set objectives of the study; each
participant will be ensured anonymity. Following data analysis,
consolidated results will be published. A signed, informed consent
form will be required for participation from the parents/caregivers.
The Internal Review Board (IRB) committee of Mohammed Bin
Rashid University of Medicine and Health Sciences in (MBRU) in
Dubai, UAE have approved the study (Reference: MBRU-IRB-2018-
014).
Dissemination of the study’s results
The detailed results and conclusive outcome(s) of the study will be
disseminated through peer-reviewed publication/s, conference
presentations and the MBRU web site. Additional events will be
conducted by inviting stakeholders and groups of interest in
inhalation sedation (such as dental teams including general dental
practitioners, dental nurses, paediatric dental specialists and
consultants to discuss our findings as it will be relevant to all
those who manage children who have dental anxiety generally
and those using N2O specifically).
The study’s statistical analysis
We will conduct deep statistical analysis after consideration of the
data’s distribution normality, with the appropriate parametric or
non-parametric statistical tests using the statistical software SPSS™
24.0.0 (SPSS© Inc., USA). The utilisation of standard descriptive
statistics and quantitative data will be reported; if normally
distributed, means and standard deviations shall be used; and if
skewed, medians and interquartile ranges will be reported. The
score of dental anxiety will be calculated for each participant and
test for normality by using the Shapiro–Wilk test. Categorical data
will be tested for independency by using Chi-square or Fisher's
exact test when appropriate. The difference in the means between
the two groups will be tested using either t-test or Mann–Whitney
test depending on the normality of the data. The comparison of
the means of more than two variables will be tested by using
ANOVA or Kruskal–Wallis depending on the normality of the
Table 2. Modified Child Dental Anxiety Scores (MCDAS).
Score Interpretation
5–10 Minimal anxiety
11–18 Moderate anxiety
≥19 Severe anxiety
Fig. 3 A child wearing the E4 wrist watch.
Fig. 2 Modified Child Dental Anxiety Scale Faces Version (Source: SDCEP Oral Health Assessment and Review 2017).11
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measurements. A p-value of <0.05 will be considered significant in
all tests.
DISCUSSION
The purpose of this study/protocol is to provide an evidence
supported answer regarding the clinical value of the use of an
additional acclimatising visit for N2O prior to the actual planned
dental treatment. Nitrous oxide inhalation sedation has been
employed in dentistry for over 170 years. Recently, there has been
interest for stronger evidence to back its use both generally and in
dentistry.19 Nevertheless, N2O use has been strongly advocated by
major international paediatric dentistry organisations. For exam-
ple, the American Academy of Pediatric Dentistry (AAPD)
recognises nitrous oxide/oxygen inhalation as a safe and effective
anxiolytic technique proven to reduce dental anxiety that provides
mild analgesia and enhances effective communication between a
child patient and dental health care provider (AAPD 2015).1 The
SDCEP (2017) recommends the use of inhalation sedation with
nitrous oxide/oxygen as the preferred method for conscious
sedation.2 These endorsements echo the guidelines of other
entities such as the UK dental faculties of the Royal Colleges of
Surgeons and the Royal College of Anaesthetists. The latter, in
2015, recommended two visits for inhalation sedation—one
preparatory (for assessment purposes for suitability for sedation
only) and the other one for the actual treatment.9
The employment of an acclimatisation session prior to dental
treatment under N2O has been suggested by some authors of
Fig. 4 The screenshot from the real-time physiological parameter interface obtained from the E4® watch analytical software.
Table 3. Treatment complexity rank score.
Rank Description Score
Routine Polishing, fluoride application, fissure sealants, one-surface Restorations 1
Intermediate 2-surface restorations, extraction of 1 primary tooth, one-quadrant restorative dentistry 2
Complex Crown preparation, pulp treatment, extraction of multiple primary teeth, multiple-quadrant restorative dentistry, extraction
of 1 permanent tooth
3
High complexity Multiple extractions of permanent teeth, surgical extractions, biopsy. Any treatment considered more complex than above
or are multiples of the above
4
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prominent textbooks in paediatric dentistry since 1980,8 under the
well-known paediatric dentistry behaviour management principle
of Tell–Show–Do.20,21 However, the specific advantages of the use
of this technique have not been investigated properly.
An additional resource that recommended the use of accus-
toming visit was the SDCEP in 2017.2 They issued the following
statement without specific supportive evidence: “A brief trial of
nitrous oxide/oxygen at the assessment appointment may be helpful
for the psychological preparation of some children”. Thus, currently,
the guidelines recommendations are based on collective expert
opinion and are not evidence based.
The outcomes of this research will provide some evidence on
whether or not a separate session for acclimatisation to N2O/O2
sedation should be offered and whether such extra visit increases
the effectiveness of this safe method of sedation to treat anxious
children in the clinic. In addition, the requirement of a lengthy
time of no oral feeding renders GA a challenge in some young and
medically compromised children.22–24 Furthermore, dental treat-
ment under N2O will decrease treatment costs by about a third,
thus avoiding expensive GA hospital admissions.25 Although a
recent Cochrane report26 highlighted that evidence to support the
superiority of GA over N2O sedation for providing dental care to
children is lacking, the safety of the latter is not in question. Our
research aims at improving our knowledge in relation to the use of
N2O, a time-tested method that has cemented its position in the
armamentarium available in dealing with anxious dental patients.
Data statement
Anonymous participants’ data may be shared on request to
promote a culture of openness and an increased sharing of
research data. Our information sheet and informed consent clearly
state that the collected data are intended to be used for research
purposes, and possibly published in dental journals and presented
at conferences. All the anonymously collected data can be shared
upon request from the primary investigator once the study is
completed. The data will be stored for 5 years after the final
publication to be shared upon request.
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